Attitudes Regarding Medications for Opioid Use Disorder Among Peer Recovery Coaches

被引:4
|
作者
Suzuki, Joji [1 ,2 ,3 ]
Loguidice, Frank [1 ]
Martin, Bianca [1 ]
机构
[1] Brigham & Womens Hosp, Boston, MA USA
[2] Harvard Med Sch, Boston, MA USA
[3] Brigham & Womens Hosp, 60 Fenwood Rd, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
opioid use disorder; peer support; recovery coach; SERVICES;
D O I
10.1097/ADM.0000000000001025
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
ObjectivesA growing number of individuals are employed as peer recovery coaches to mentor, support, and educate those in recovery. Despite the robust evidence base for the benefits of medications for treating opioid use disorder (OUD), prior research has identified peers in recovery to hold both positive and negative attitudes toward medications for OUD (MOUDs). We aimed to survey peer recovery coaches in Massachusetts about their attitudes toward working with individuals utilizing MOUDs.MethodsAll 202 individuals certified as peer recovery coaches in Massachusetts were invited to participate in a brief, anonymous online survey between August and October 2020. The survey collected the respondents' age, sex, certification year, duration of employment as a coach, personal history of substance use disorders, and MOUD treatment.ResultsA total of 129 responses were received, representing a 63.9% response rate. Eighty-six (64.3%) reported a personal history of OUD, of whom 64 (74.4%) reported prior MOUD treatment. The majority held positive views about MOUDs, endorsing them as appropriate treatments to achieve sobriety. Coaches with personal history of MOUDs were more likely to report enjoying working with patients on methadone. Coaches without any personal history of OUD or MOUDs were older, more likely to have an alcohol use disorder, and more likely to encourage drug-free treatments before MOUDs and shorter duration of MOUD treatment.ConclusionsResults indicate that peer recovery coaches in Massachusetts hold generally positive attitudes toward MOUDs, but those without any personal history of OUD or MOUDs may be less likely to encourage MOUD treatment.
引用
收藏
页码:101 / 103
页数:3
相关论文
共 50 条
  • [31] Prescribers’ satisfaction with delivering medications for opioid use disorder
    Hannah K. Knudsen
    Randy Brown
    Nora Jacobson
    Julie Horst
    Jee-Seon Kim
    Hanna Kim
    Lynn M. Madden
    Eric Haram
    Todd Molfenter
    Substance Abuse Treatment, Prevention, and Policy, 16
  • [32] Prescribers' satisfaction with delivering medications for opioid use disorder
    Knudsen, Hannah K.
    Brown, Randy
    Jacobson, Nora
    Horst, Julie
    Kim, Jee-Seon
    Kim, Hanna
    Madden, Lynn M.
    Haram, Eric
    Molfenter, Todd
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2021, 16 (01)
  • [33] Perspectives on electronic portal use among patients treated with medications for opioid use disorder in primary care
    Chen, Joan
    Cabudol, MarkJason
    Williams, Emily C.
    Merrill, Joseph O.
    Tsui, Judith I.
    Klein, Jared W.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2021, 126
  • [34] Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder
    Cardamone, Nicholas C.
    Stewart, Rebecca E.
    Kampman, Kyle M.
    Marcus, Steven C.
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2025, 20 (01):
  • [35] Correlates and Patterns in Use of Medications to Treat Opioid Use Disorder in Jail
    Bailey, Amelia
    Senthilkumar, Rithika
    Evans, Elizabeth A.
    JOURNAL OF ADDICTION MEDICINE, 2023, 17 (05) : 568 - 573
  • [36] The impact of psychiatric comorbidity on treatment discontinuation among individuals receiving medications for opioid use disorder
    Friesen, Erik Loewen
    Kurdyak, Paul
    DRUG AND ALCOHOL DEPENDENCE, 2020, 216
  • [37] Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid Review
    Mackey, Katherine
    Veazie, Stephanie
    Anderson, Johanna
    Bourne, Donald
    Peterson, Kim
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 3) : 954 - 963
  • [38] Outcomes associated with the use of medications for opioid use disorder during pregnancy
    Krans, Elizabeth E.
    Kim, Joo Yeon
    Chen, Qingwen
    Rothenberger, Scott D.
    James, Alton Everette
    Kelley, David
    Jarlenski, Marian P.
    ADDICTION, 2021, 116 (12) : 3504 - 3514
  • [39] Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid Review
    Katherine Mackey
    Stephanie Veazie
    Johanna Anderson
    Donald Bourne
    Kim Peterson
    Journal of General Internal Medicine, 2020, 35 : 954 - 963
  • [40] Receipt of medications for opioid use disorder among rural and urban veterans health administration patients
    Reynolds, Olivia C.
    Carlson, Kathleen F.
    Gordon, Adam J.
    Handley, Robert L.
    Morasco, Benjamin J.
    Korthuis, Todd P.
    Lovejoy, Travis I.
    Wyse, Jessica J.
    DRUG AND ALCOHOL DEPENDENCE REPORTS, 2025, 14